Brief: Canbridge Pharmaceuticals Announces CAN 103 Included In China's Innovative Drug List
08/12/2025 15:26
Dec 8 (Reuters) - Canbridge Pharmaceuticals Inc 1228.HK: CAN 103 INCLUDED IN CHINA'S INNOVATIVE DRUG LIST Further company coverage: 1228.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CANbridge Pharmaceuticals
See all newsChina's CANbridge Pharmaceuticals H1 revenue rises on Hunterase and Livmarli strength
Brief: CANbridge Pharmaceuticals Posts HY Loss of RMB37.1 MLN
Brief: Canbridge Pharmaceuticals Says Livmarli Obtains NHIA Reimbursement Approval In Taiwan For ALGS And PFIC
Brief: Canbridge Pharmaceuticals Initiates Registration And Launch Preparations For Gaurunning In North African Market
CANbridge Pharmaceuticals jumps as WuXi Biologics buys shares